AAPL341.31-3.33 (-0.96%) ▼|ABBV287.61-7.28 (-2.47%) ▼|ABT108.53+2.33 (+2.19%) ▲|ACN260.97+2.73 (+1.06%) ▲|ADBE252.72+2.49 (+0.99%) ▲|AMAT393.50+3.41 (+0.87%) ▲|AMD492.72-12.09 (-2.39%) ▼|AMGN461.53-4.48 (-0.96%) ▼|AMT187.25-0.53 (-0.28%) ▼|AMZN251.70+11.35 (+4.72%) ▲|AVGO332.70+6.62 (+2.03%) ▲|AXP327.48+8.37 (+2.62%) ▲|BA176.42+4.87 (+2.84%) ▲|BAC50.02+0.01 (+0.02%) ▲|BKNG155.00+6.87 (+4.64%) ▲|BLK1,174.36+26.82 (+2.34%) ▲|BMY62.54+0.06 (+0.09%) ▲|BNY148.04+0.93 (+0.63%) ▲|BRK-B550.78+8.29 (+1.53%) ▲|C123.59+1.62 (+1.33%) ▲|CAT619.65-3.10 (-0.50%) ▼|CL96.39+1.10 (+1.15%) ▲|CMCSA23.62+0.40 (+1.70%) ▲|COF210.48+5.63 (+2.75%) ▲|COP149.02-5.02 (-3.26%) ▼|COST1,027.81+15.53 (+1.53%) ▲|CRM231.15+1.98 (+0.86%) ▲|CSCO103.54-0.97 (-0.93%) ▼|CVS88.29-1.96 (-2.17%) ▼|CVX231.07-4.46 (-1.89%) ▼|DE674.37-1.11 (-0.16%) ▼|DHR228.23-4.00 (-1.72%) ▼|DIS112.91+1.97 (+1.78%) ▲|DUK127.09-0.30 (-0.24%) ▼|EMR168.84+3.90 (+2.36%) ▲|FDX320.10+6.82 (+2.18%) ▲|GD369.87-2.72 (-0.73%) ▼|GE313.61+11.81 (+3.91%) ▲|GEV889.40+31.53 (+3.68%) ▲|GILD167.87-2.81 (-1.65%) ▼|GM89.32+1.92 (+2.20%) ▲|GOOG281.51+3.29 (+1.18%) ▲|GOOGL283.11+3.27 (+1.17%) ▲|GS911.73+17.18 (+1.92%) ▲|HD338.79+9.59 (+2.91%) ▲|HON224.57+6.24 (+2.86%) ▲|IBM259.55+1.74 (+0.67%) ▲|INTC63.06-2.71 (-4.11%) ▼|INTU351.96+10.87 (+3.19%) ▲|ISRG440.39+8.38 (+1.94%) ▲|JNJ268.46-4.74 (-1.74%) ▼|JPM340.52+3.48 (+1.03%) ▲|KO95.08+1.00 (+1.06%) ▲|LIN520.56+6.32 (+1.23%) ▲|LLY1,409.41-8.14 (-0.57%) ▼|LMT637.85+0.90 (+0.14%) ▲|LOW216.09+7.02 (+3.36%) ▲|LRCX236.32-2.80 (-1.17%) ▼|MA657.31+19.30 (+3.02%) ▲|MCD263.20+5.08 (+1.97%) ▲|MDLZ65.78+0.84 (+1.29%) ▲|MDT97.69+1.15 (+1.19%) ▲|META610.35-4.64 (-0.75%) ▼|MMM179.02+4.68 (+2.68%) ▲|MO77.53-0.51 (-0.65%) ▼|MRK148.15-1.37 (-0.92%) ▼|MS186.83+2.53 (+1.37%) ▲|MSFT524.18+2.27 (+0.43%) ▲|MU868.15-16.59 (-1.88%) ▼|NEE84.44+0.73 (+0.87%) ▲|NFLX62.01-0.07 (-0.11%) ▼|NKE39.35+0.68 (+1.76%) ▲|NOW107.66+2.54 (+2.42%) ▲|NVDA207.32+2.68 (+1.31%) ▲|ORCL123.15-7.52 (-5.76%) ▼|PEP139.14+1.80 (+1.31%) ▲|PFE30.44-0.08 (-0.26%) ▼|PG162.80+1.23 (+0.76%) ▲|PLTR184.77+0.66 (+0.36%) ▲|PM207.53-1.27 (-0.61%) ▼|QCOM167.25+2.46 (+1.49%) ▲|RTX200.75+0.95 (+0.48%) ▲|SBUX103.09-0.56 (-0.54%) ▼|SCHW89.12+1.07 (+1.22%) ▲|SO93.68-0.03 (-0.03%) ▼|SPG221.57+3.82 (+1.75%) ▲|T21.54+0.13 (+0.61%) ▲|TMO682.98-14.02 (-2.01%) ▼|TMUS157.86+1.42 (+0.91%) ▲|TSLA411.73+11.92 (+2.98%) ▲|TXN308.26+7.42 (+2.47%) ▲|UBER67.26+2.01 (+3.08%) ▲|UNH396.22-10.75 (-2.64%) ▼|UNP306.96+2.96 (+0.97%) ▲|UPS109.47+1.22 (+1.13%) ▲|USB60.27+0.82 (+1.38%) ▲|V425.29+11.70 (+2.83%) ▲|VZ45.12+0.39 (+0.86%) ▲|WFC84.73+1.33 (+1.59%) ▲|WMT126.05+2.54 (+2.06%) ▲|XOM181.41-5.84 (-3.12%) ▼|AAPL341.31-3.33 (-0.96%) ▼|ABBV287.61-7.28 (-2.47%) ▼|ABT108.53+2.33 (+2.19%) ▲|ACN260.97+2.73 (+1.06%) ▲|ADBE252.72+2.49 (+0.99%) ▲|AMAT393.50+3.41 (+0.87%) ▲|AMD492.72-12.09 (-2.39%) ▼|AMGN461.53-4.48 (-0.96%) ▼|AMT187.25-0.53 (-0.28%) ▼|AMZN251.70+11.35 (+4.72%) ▲|AVGO332.70+6.62 (+2.03%) ▲|AXP327.48+8.37 (+2.62%) ▲|BA176.42+4.87 (+2.84%) ▲|BAC50.02+0.01 (+0.02%) ▲|BKNG155.00+6.87 (+4.64%) ▲|BLK1,174.36+26.82 (+2.34%) ▲|BMY62.54+0.06 (+0.09%) ▲|BNY148.04+0.93 (+0.63%) ▲|BRK-B550.78+8.29 (+1.53%) ▲|C123.59+1.62 (+1.33%) ▲|CAT619.65-3.10 (-0.50%) ▼|CL96.39+1.10 (+1.15%) ▲|CMCSA23.62+0.40 (+1.70%) ▲|COF210.48+5.63 (+2.75%) ▲|COP149.02-5.02 (-3.26%) ▼|COST1,027.81+15.53 (+1.53%) ▲|CRM231.15+1.98 (+0.86%) ▲|CSCO103.54-0.97 (-0.93%) ▼|CVS88.29-1.96 (-2.17%) ▼|CVX231.07-4.46 (-1.89%) ▼|DE674.37-1.11 (-0.16%) ▼|DHR228.23-4.00 (-1.72%) ▼|DIS112.91+1.97 (+1.78%) ▲|DUK127.09-0.30 (-0.24%) ▼|EMR168.84+3.90 (+2.36%) ▲|FDX320.10+6.82 (+2.18%) ▲|GD369.87-2.72 (-0.73%) ▼|GE313.61+11.81 (+3.91%) ▲|GEV889.40+31.53 (+3.68%) ▲|GILD167.87-2.81 (-1.65%) ▼|GM89.32+1.92 (+2.20%) ▲|GOOG281.51+3.29 (+1.18%) ▲|GOOGL283.11+3.27 (+1.17%) ▲|GS911.73+17.18 (+1.92%) ▲|HD338.79+9.59 (+2.91%) ▲|HON224.57+6.24 (+2.86%) ▲|IBM259.55+1.74 (+0.67%) ▲|INTC63.06-2.71 (-4.11%) ▼|INTU351.96+10.87 (+3.19%) ▲|ISRG440.39+8.38 (+1.94%) ▲|JNJ268.46-4.74 (-1.74%) ▼|JPM340.52+3.48 (+1.03%) ▲|KO95.08+1.00 (+1.06%) ▲|LIN520.56+6.32 (+1.23%) ▲|LLY1,409.41-8.14 (-0.57%) ▼|LMT637.85+0.90 (+0.14%) ▲|LOW216.09+7.02 (+3.36%) ▲|LRCX236.32-2.80 (-1.17%) ▼|MA657.31+19.30 (+3.02%) ▲|MCD263.20+5.08 (+1.97%) ▲|MDLZ65.78+0.84 (+1.29%) ▲|MDT97.69+1.15 (+1.19%) ▲|META610.35-4.64 (-0.75%) ▼|MMM179.02+4.68 (+2.68%) ▲|MO77.53-0.51 (-0.65%) ▼|MRK148.15-1.37 (-0.92%) ▼|MS186.83+2.53 (+1.37%) ▲|MSFT524.18+2.27 (+0.43%) ▲|MU868.15-16.59 (-1.88%) ▼|NEE84.44+0.73 (+0.87%) ▲|NFLX62.01-0.07 (-0.11%) ▼|NKE39.35+0.68 (+1.76%) ▲|NOW107.66+2.54 (+2.42%) ▲|NVDA207.32+2.68 (+1.31%) ▲|ORCL123.15-7.52 (-5.76%) ▼|PEP139.14+1.80 (+1.31%) ▲|PFE30.44-0.08 (-0.26%) ▼|PG162.80+1.23 (+0.76%) ▲|PLTR184.77+0.66 (+0.36%) ▲|PM207.53-1.27 (-0.61%) ▼|QCOM167.25+2.46 (+1.49%) ▲|RTX200.75+0.95 (+0.48%) ▲|SBUX103.09-0.56 (-0.54%) ▼|SCHW89.12+1.07 (+1.22%) ▲|SO93.68-0.03 (-0.03%) ▼|SPG221.57+3.82 (+1.75%) ▲|T21.54+0.13 (+0.61%) ▲|TMO682.98-14.02 (-2.01%) ▼|TMUS157.86+1.42 (+0.91%) ▲|TSLA411.73+11.92 (+2.98%) ▲|TXN308.26+7.42 (+2.47%) ▲|UBER67.26+2.01 (+3.08%) ▲|UNH396.22-10.75 (-2.64%) ▼|UNP306.96+2.96 (+0.97%) ▲|UPS109.47+1.22 (+1.13%) ▲|USB60.27+0.82 (+1.38%) ▲|V425.29+11.70 (+2.83%) ▲|VZ45.12+0.39 (+0.86%) ▲|WFC84.73+1.33 (+1.59%) ▲|WMT126.05+2.54 (+2.06%) ▲|XOM181.41-5.84 (-3.12%) ▼|
17 C
New York
Monday, November 2, 2026

Tag: form

newsFORsourcecompanycontentinformationreleases1market

מועד אחרון חשוב לתביעה נגד VSTS: רוזן, משרד עורכי דין מוביל לזכויות משקיעים, מעודד את משקיעי Vestis Corporation עם הפסדים של יותר מ-100 אלף...

ניו יורק, Aug. 04, 2025 (GLOBE NEWSWIRE) --

מדוע: משרד רוזן עורכי דין (Rosen Law Firm), משרד עורכי דין בינלאומי העוסק בזכויות משקיעים, מזכיר לרוכשים את ניירות הערך של  Vestis Corporation (NYSE: VSTS) בין התאריכים 2 במאי 2024 עד 6 במאי 2025, שני התאריכים כוללים ("התקופה הייצוגית"), את המועד האחרון החשוב של 8 באוגוסט 2025 להגשת תביעה ייצוגית בניירות ערך.

ROSEN, A LEADING NATIONAL FIRM, Encourages Capricor Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – CAPR

NEW YORK, Aug. 03, 2025 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Capricor Therapeutics, Inc. (NASDAQ: CAPR) between October 9, 2024 and July 10, 2025, both dates inclusive (the “Class Period”), of the important September 15, 2025 lead plaintiff deadline.

RDDT IMPORTANT DEADLINE: ROSEN, SKILLED INVESTOR COUNSEL, Encourages Reddit, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in...

NEW YORK, Aug. 03, 2025 (GLOBE NEWSWIRE) -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Reddit, Inc. (NYSE: RDDT) between October 29, 2024 and May 20, 2025, both dates inclusive (the “Class Period”), of the important August 18, 2025 lead plaintiff deadline.

ROSEN, A LEADING NATIONAL FIRM, Encourages Centene Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – CNC

NEW YORK, Aug. 03, 2025 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Centene Corporation (NYSE: CNC) between December 12, 2024 and June 30, 2025, both dates inclusive (the “Class Period”), of the important September 8, 2025 lead plaintiff deadline.

KBR Investor News: If You Have Suffered Losses in KBR, Inc. (NYSE: KBR), You Are Encouraged to Contact The Rosen Law Firm About Your...

NEW YORK, Aug. 03, 2025 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of KBR, Inc. (NYSE: KBR) resulting from allegations that KBR may have issued materially misleading business information to the investing public.

מחר המועד האחרון לתביעה נגד RBGLY: רוזן, משרד עורכי דין מוביל, מעודד את משקיעי Reckitt Benckiser Group PLC להשיג ייעוץ לפני המועד האחרון החשוב...

ניו יורק, Aug. 03, 2025 (GLOBE NEWSWIRE) --

מדוע: משרד רוזן עורכי דין (Rosen Law Firm), משרד עורכי דין בינלאומי העוסק בזכויות משקיעים, מזכיר לרוכשים את מניות הפיקדון האמריקאיות ("ADS") של  Reckitt Benckiser Group PLC (OTC: RBGLY) בין התאריכים 13 בינואר 2021 עד 28 ביולי 2024, שני התאריכים כוללים ("התקופה הייצוגית"), את המועד האחרון החשוב של 4 באוגוסט 2025 להגשת תביעה ייצוגית בניירות ערך.

RBGLY DEADLINE TOMORROW: ROSEN, A TOP RANKED LAW FIRM, Encourages Reckitt Benckiser Group PLC Investors to Secure Counsel Before Important August 4 Deadline in...

NEW YORK, Aug. 03, 2025 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of American Depositary Shares (“ADSs”) of Reckitt Benckiser Group PLC (OTC: RBGLY) between January 13, 2021 and July 28, 2024, both dates inclusive (the “Class Period”), of the important August 4, 2025 lead plaintiff deadline.

התראת מועד לתביעה נגד DDD: רוזן, יועץ גלובלי מוביל, מעודד משקיעים בתאגיד 3D Systems עם הפסדים של יותר מ-100 אלף דולר להשיג ייעוץ לפני...

ניו יורק, Aug. 03, 2025 (GLOBE NEWSWIRE) --

מדוע: משרד רוזן עורכי דין (Rosen Law Firm), משרד עורכי דין בינלאומי העוסק בזכויות משקיעים, מזכיר לרוכשים את ניירות הערך של  3D Systems Corporation  (NYSE: DDD) בין התאריכים 13 באוגוסט 2024 עד 12 במאי 2025, שני התאריכים כוללים ("התקופה הייצוגית"), את המועד האחרון החשוב של 12 באוגוסט 2025 להגשת תביעה ייצוגית בניירות ערך.

מועד אחרון לתביעה נגד PEPG: רוזן, יועץ למשקיעים מוביל, מעודד את משקיעי PepGen Inc להשיג ייעוץ לפני המועד האחרון החשוב של 8 באוגוסט בתביעה...

ניו יורק, Aug. 03, 2025 (GLOBE NEWSWIRE) --

מדוע: משרד רוזן עורכי דין (Rosen Law Firm), משרד עורכי דין בינלאומי העוסק בזכויות משקיעים, מזכיר לרוכשים את ניירות הערך של  PepGen Inc. (נאסד"ק: PEPG) בין התאריכים 7 במרץ 2024 עד 3 במרץ 2025, שני התאריכים כוללים ("התקופה הייצוגית"), את המועד האחרון החשוב של 8 באוגוסט 2025 להגשת תביעה ייצוגית בניירות ערך.

Ingredion Incorporated, 견조한 2분기 실적 발표 및 연간 전망 상향 조정

일리노이주 웨스트체스터, Aug. 03, 2025 (GLOBE NEWSWIRE) -- 식품 및 음료 제조업계에 각종 원료 솔루션을 공급하는 글로벌 리더 Ingredion Incorporated(NYSE: INGR)가 2025년 2분기 실적을 발표했다

Pilly Labs Aligns with 2025 Demand for the Best Nutritional Gummies Supporting Whole Body Wellness

In a year defined by holistic health trends, anti-inflammatory nutrition stacks, and consumer-led demand for clean-label routines, Pilly Labs is emerging as a go-to gummy supplement brand for wellness seekers prioritizing transparency and convenience. With turmeric, mushroom extracts, and collagen continuing to dominate 2025’s ingredient interest charts, Pilly Labs’ natural formulations are gaining traction across TikTok rituals, Google search trends, and Reddit supplement stacks — not as prescriptions, but as daily wellness additions for those exploring inflammation support and whole body vitality. 
In a year defined by holistic health trends, anti-inflammatory nutrition stacks, and consumer-led demand for clean-label routines, Pilly Labs is emerging as a go-to gummy supplement brand for wellness seekers prioritizing transparency and convenience. With turmeric, mushroom extracts, and collagen continuing to dominate 2025’s ingredient interest charts, Pilly Labs’ natural formulations are gaining traction across TikTok rituals, Google search trends, and Reddit supplement stacks — not as prescriptions, but as daily wellness additions for those exploring inflammation support and whole body vitality.

Pilly Labs Formulates 2025’s Top Mushroom Extract Gummies Supplement for ADHD Focus, Anxiety Support, and Natural Weight Wellness

As 2025 consumers increasingly seek natural ways to support attention, emotional balance, and metabolic wellness, Pilly Labs introduces a fruiting body mushroom gummy blend featuring Lion’s Mane, Reishi, and Cordyceps—positioned at the intersection of convenience, cognitive clarity, and ingredient transparency. 
As 2025 consumers increasingly seek natural ways to support attention, emotional balance, and metabolic wellness, Pilly Labs introduces a fruiting body mushroom gummy blend featuring Lion’s Mane, Reishi, and Cordyceps—positioned at the intersection of convenience, cognitive clarity, and ingredient transparency.

Collagen Supplement Trends in 2025: Why Pilly Labs Collagen Gummies Are Leading the Natural Glow-Up Movement

As consumer demand for clean beauty and functional supplements rises in 2025, marine collagen gummies like Pilly Labs are emerging as a preferred daily solution for supporting skin texture, joint mobility, and hair strength — all without powders, pills, or synthetic additives. 
As consumer demand for clean beauty and functional supplements rises in 2025, marine collagen gummies like Pilly Labs are emerging as a preferred daily solution for supporting skin texture, joint mobility, and hair strength — all without powders, pills, or synthetic additives.

ROSEN, SKILLED INVESTOR COUNSEL, Encourages Fiserv, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – FI

NEW YORK, Aug. 02, 2025 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Fiserv, Inc. (NYSE: FI) between July 24, 2024 and July 22, 2025, both dates inclusive (the “Class Period”), of the important September 22, 2025 lead plaintiff deadline.

- A word from our sponsors -

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsForm

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers